Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune...
responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(1191)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 15, 2024 11:17am
RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
Oopsy Daisies Quenty!
(5041)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 15, 2024 10:48am
RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
I guess that Quentin30 doesn't know how to read given that ONCY's pelareorep does not require cold chain storage. In 2009 Oncolytics Biotech Inc. (“Oncolytics”) (TSX:ONC, NASDAQ:ONCY
...more
(151)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Apr 15, 2024 10:46am
RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
These forever pumpers remind me of the make believe on Charlie and the chocolate factory... they live in a mythical world and can't deal with reality. They have that huge wall around them so
...more
(67)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Apr 15, 2024 10:40am
RE:RE:RE:Quentin30 is a pathological prevaricator.
Let's see how well today's panel discussion works out for ONCY shall we... I speak of cold chain storage requirements, and you dismiss this as a non-concern. Really??? How on earth do
...more
(454)
•••
Lesalpes29
X
View Profile
View Bullboard History
Comment by
Lesalpes29
on Apr 15, 2024 7:29am
RE:RE:RE:New things? Up & coming.
News before next any presentation. News before year end. News before any conference call. News before the eclipse! News before next AGM. Don't know for you but all those call are all wrong
...more
(850)
•••
canadafan
X
View Profile
View Bullboard History
Comment by
canadafan
on Apr 14, 2024 5:52pm
RE:RE:New things? Up & coming.
Thanks for the kind words. Contrary to a few others opinions, I work hard at printing something of substance. i ,as much as possible qualify an oppinion from fact. Yes, my estimates have been wrong.
...more
(341)
•••
Peladawn
X
View Profile
View Bullboard History
Comment by
Peladawn
on Apr 14, 2024 5:01pm
RE:New things? Up & coming.
Thanks for that cf.....I always appreciate your analysis....I, too, ,believe we'll see something before the agm, in fact much sooner, maybe even as soon as tomorrow morning...but that's
...more
(850)
•••
canadafan
X
View Profile
View Bullboard History
Post by
canadafan
on Apr 14, 2024 4:42pm
New things? Up & coming.
I enjoy reasonable questions. such as when will we receive update & panc trail ? That m BTW could become the billion $ question. Reading the published information & reading between the
...more
(341)
•••
Peladawn
X
View Profile
View Bullboard History
Comment by
Peladawn
on Apr 14, 2024 3:49pm
RE:RE:RE:RE:RE:RE:RE:RE:FDA ready to review novel cancer vaccine Platform Technology
Hey Note....how soon do think we'll hear something about the panc registrational trial?
(5041)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 14, 2024 3:27pm
RE:RE:RE:RE:RE:RE:RE:FDA ready to review novel cancer vaccine Platform Technology
Who? Remember that lonc17 would have one invest in a phoney $3 bill rather than ONCY. That's also who.
(341)
•••
Peladawn
X
View Profile
View Bullboard History
Comment by
Peladawn
on Apr 14, 2024 2:37pm
RE:RE:RE:RE:RE:RE:FDA ready to review novel cancer vaccine Platform Technology
A virus that works and works well in all the right areas, and is now going into likely two registrational studies(maybe 3), that will support Accelerated Aproval!......Who the heck would be fool
...more
(5041)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 14, 2024 12:20pm
RE:RE:RE:RE:RE:FDA ready to review novel cancer vaccine Platform Technology
ONCY's dsRNA virus is the ONLY biomarker driven RNA oncolytic virus in late-stage clinical development with/without immune checkpoint inhibitors + chemotherapy.for the treatment of multiple
...more
(5041)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 13, 2024 9:27pm
RE:RE:RE:RE:FDA ready to review novel cancer vaccine Platform Technology
New medicines, particularly biologics in the treatment of cancer, are increasingly being identified as efficacious across multiple cancer indications and can be viewed from a commercial and
...more
(5041)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 13, 2024 4:30pm
RE:RE:RE:RE:AACR 2024 : Cancer vaccines get reintroduction with pathway
Perspectives: Although 5 decades of research have yielded many failures, "vaccines"; such as ONCY's platfrom drug pelareorep, are now positioned for success for several reasons
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test